Clinical Trial Update: Study of MRI Guided Personal Chemoradiotherapy and Immunotherapy for Limited Advanced Esophageal Squamous Caicinoma. [Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 2 study of MRI-guided personalized chemoradiotherapy plus immunotherapy for limited advanced unresectable esophageal squamous …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Fudan University | Conditions: Advanced Esophageal Squamous Cell Carcinoma, Unresectable Esophageal Squamous Cell Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING